Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis
Sponsored by Kowa Research Institute, Inc.
About this trial
Last updated 3 years ago
Study ID
K-321-201
Status
Completed
Type
Interventional
Phase
Phase 2
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 3 years ago
What is this trial about?
The objective of this study is to investigate the effect of K-321 in patients with Fuchs
endothelial corneal dystrophy (FECD) after descemetorhexis.
What are the participation requirements?
Inclusion Criteria
- Is at least 18 years old at the screening visit (Visit 1).
- Has a diagnosis of FECD at Visit 1.
- Meet all other inclusion criteria outlined in clinical study protocol.
Exclusion Criteria
- Has a study eye with a history of cataract surgery within 90 days of Visit 1.
- Has a study eye with a history of any previous ocular surgery other than for cataract.
- Meet any other exclusion criteria outlined in clinical study protocol.